Last update 07 Jun 2025

iPD1 CD19 eCAR-T therapy(Beijing Mali Biotechnology Co Ltd)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
Anti-CD19 4-1BB-costimulatory chimeric antigen receptor T cell therapy, iPD1 CD19 eCAR T cells, MBC19
Target
CD19
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Diffuse Large B-Cell Lymphoma
Inactive Indication-
Originator Organization
Beijing Mali Biotechnology Co LtdBeijing Mali Biotechnology Co Ltd
Active Organization
Chengdu Yinhe Biomedicine Co LtdChengdu Yinhe Biomedicine Co LtdSichuan UniversitySichuan UniversityBeijing Mali Biotechnology Co LtdBeijing Mali Biotechnology Co Ltd
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationPriority Review (China)
Login to view timeline

Related

1
Clinical Trials associated with iPD1 CD19 eCAR-T therapy(Beijing Mali Biotechnology Co Ltd)
CTR20190470
/ RecruitingPhase 1
评价MBC19治疗复发性或难治性B细胞淋巴瘤的安全性及有效性、药代动力学特征的单中心I期临床研究
[Translation] A single-center phase I clinical study to evaluate the safety, efficacy, and pharmacokinetic characteristics of MBC19 in the treatment of relapsed or refractory B-cell lymphoma
100 Clinical Results associated with iPD1 CD19 eCAR-T therapy(Beijing Mali Biotechnology Co Ltd)
Login to view more data
100 Translational Medicine associated with iPD1 CD19 eCAR-T therapy(Beijing Mali Biotechnology Co Ltd)
Login to view more data
100 Patents (Medical) associated with iPD1 CD19 eCAR-T therapy(Beijing Mali Biotechnology Co Ltd)
Login to view more data
100 Deals associated with iPD1 CD19 eCAR-T therapy(Beijing Mali Biotechnology Co Ltd)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diffuse Large B-Cell LymphomaPhase 1
China
Chengdu Yinhe Biomedicine Co LtdChengdu Yinhe Biomedicine Co Ltd
05 Aug 2021
Diffuse Large B-Cell LymphomaPhase 1
China
Sichuan UniversitySichuan University
05 Aug 2021
Diffuse Large B-Cell LymphomaPhase 1
China
Beijing Mali Biotechnology Co LtdBeijing Mali Biotechnology Co Ltd
05 Aug 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free